Firstly, the presence of autoantibodies predicts and confirms the onset of the disease along with the clinical symptoms; therefore, the ANA patterns assist to evaluate the subtypes and the main clinical manifestations of Ssc. The gene discussed is BTG3; the disease is systemic sclerosis.